SIStockInvestingSI.com

NYSE · ELV · Healthcare Plans

Elevance Health (ELV) stock analysis

$434.13−1.37%Data as of Oct 21, 2026
  • ELV gained 7.9% over the past month versus 0.0% for the S&P 500, ranking 93rd of 497 S&P 500 stocks.
  • Over 12 months it returned +24.0%, 8.2 points ahead of the S&P 500, and trades 1.4% below its 52-week high.
  • In the last 30 days 2 analysts raised earnings estimates and 1 cut; forward EPS moved +0.6% (+0.3% over 90 days).
  • It sits in the Health insurers segment of the Healthcare Value Chain, where the 1-month median return is +11.2%.
  • The daily chart reads Trend transition · Upside breakout (since Oct 20, 2026).
Market cap$94.1B
12-month return+24.0%
Forward P/E14.6×
Mean target vs price+5.0%

One-year price with 50- and 200-day averages

Open in Hub
293338383427JanAprJulOct
434.1350-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

ELV+7.9%
Sector median−8.7%
S&P 5000.0%
ELV+14.5%
Sector median−5.4%
S&P 500+4.7%
ELV+32.3%
Sector median−1.5%
S&P 500+8.7%
ELV+24.0%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 50093 / 497
3-month rank in its sector · Healthcare175 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Upside breakoutAwaiting confirmation

Holding since Oct 20, 2026

  • Close above EMA20 above EMA50
  • EMA50 rose over the last ten sessions
  • Confirmed swing highs and lows are falling
  • Volume exceeds 1.5× the prior 20-session average; supporting evidence only
  • Intermediate and long-term directions differ
This pattern on this stock

78 occurrences in 10 years. The median move over the next 20 sessions was +1.4%, positive 60% of the time, against +1.1% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$29.73
30-day change+0.6%
90-day change+0.3%
Mean target$456.00 +5.0%
Raised (30d) 2Cut (30d) 1

21 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersMomentum

Behind peersGrowth, Cash

PeersUNH · CVS · CI · HUM

Where it sits in the supply chain

Healthcare Value Chain · Payers

Explore the full chain map in Hub
Supplied by
PBMs & pharmacies+9.3%
CVS+7.3%1 monthCI+11.2%1 monthUNH+11.8%1 month6618.HK+7.3%1 month
Hospitals & care delivery+8.4%
HCA+4.9%1 monthUNH+11.8%1 month
Obesity & metabolic (GLP-1)+3.8%
LLY+8.6%1 monthNVO−0.9%1 month
Its segment
Health insurers+11.2%
UNH+11.8%1 monthELV+7.9%1 monthCI+11.2%1 monthCVS+7.3%1 monthHUM+14.4%1 month

Commercial, Medicare Advantage and Medicaid plans; the medical cost ratio and government rates matter most, and UnitedHealth usually reports first.

Sells into
Government programs & policy
Patients, employers & pet owners

Also on: Medtech, Diagnostics & Care

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−26.5%
Volatility, 60D24.8%
From 52-week high−1.4%
From 52-week low+55.6%
Trailing P/E19.2×
Forward P/E14.6×
UNHUnitedHealth GroupCICignaCVSCVS HealthHUMHumana Inc.LLYEli LillyCNCCentene CorporationJNJJohnson & JohnsonABBVAbbVie

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗